Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phenotypic drug susceptibility assay for influenza virus neuraminidase inhibitors.

Clinical and diagnostic laboratory immunology - 1 Jan 2004

McSharry James J, McDonough Ann C, Olson Betty A, Drusano George L

Abstract excerpt

A flow cytometric (fluorescence-activated cell sorter [FACS]) assay was developed for analysis of the drug susceptibilities of wild-type and drug-resistant influenza A and B virus laboratory strains and clinical isolates for the neuraminidase (NA) inhibitors oseltamivir carboxylate, zanamivir, an...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acetamides
Share to Guanidines
Share to Influenza B virus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neuraminidase

Share to Oseltamivir

Share to Pyrans

Share to Sialic Acids

Share to Zanamivir

Source

Open in PubMed Open full text

Identifiers

PMID: 14715540
DOI: 10.1128/cdli.11.1.21-28.2004
PMCID: PMC321328

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-14715540-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phenotypic drug susceptibility assay for influenza virus neuraminidase inhibitors.PMID 14715540Read ↗

Assays for monitoring susceptibility of influenza viruses to neuraminidase inhibitors.Semantic proximity Read ↗

Monitoring of viral susceptibility: new challenges with the development of influenza NA inhibitorsSemantic proximity Read ↗

Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors.Semantic proximity Read ↗

Virus susceptibility analyses from a phase IV clinical trial of inhaled zanamivir treatment in children infected with influenza.Semantic proximity Read ↗

Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors.Semantic proximity Read ↗

Phenotypic and genotypic analysis of influenza viruses isolated from adult subjects during a phase II study of intravenous zanamivir in hospitalised subjects.Semantic proximity Read ↗

Difluorosialic acids, potent novel influenza virus neuraminidase inhibitors, induce fewer drug resistance-associated neuraminidase mutations than does oseltamivir.Semantic proximity Read ↗

Reduced Sensitivity of Influenza A (H5N1) to OseltamivirSemantic proximity Read ↗

Reduced Sensitivity of Influenza A (H5N1) to OseltamivirSemantic proximity Read ↗

[Analysis of decrease in sensitivity in influenza A (H5N1) avian and human strains to neuraminidase inhibitors].Semantic proximity Read ↗

Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996–2007Semantic proximity Read ↗

Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.